Related Experiment Video
Updated: May 27, 2026
08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Familial amyotrophic lateral sclerosis, a historical perspective
1Davee Department of Neurology and Clinical Neurosciences & Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, USA.
Summary
Genetic research has identified over 10 genes linked to familial Amyotrophic Lateral Sclerosis (ALS), advancing understanding of its causes and therapies. This progress sheds light on genetic and environmental factors in sporadic ALS as well.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons.
- The etiology of ALS remains largely unknown, though genetic factors are implicated.
- Familial ALS has a known genetic component, while sporadic ALS involves complex interactions.
Purpose of the Study:
- To chronologically summarize genetic breakthroughs in familial and sporadic ALS.
- To illustrate how genetic discoveries have shaped the understanding of ALS pathogenesis.
- To highlight the impact of genetic research on the development of ALS therapies.
Main Methods:
- Review of genetic studies and breakthroughs in ALS research.
- Chronological analysis of gene identification in familial ALS.
- Examination of genetic and environmental interactions in sporadic ALS.
Main Results:
- Identification of over 10 genes associated with familial ALS in recent decades.
- Enhanced understanding of the genetic underpinnings of ALS.
- Insights into the interplay of genetic and environmental factors contributing to sporadic ALS.
Conclusions:
- Genetic research has been pivotal in understanding ALS pathogenesis.
- Advances in genetics are crucial for developing targeted therapies for ALS.
- Continued genetic investigation is essential for unraveling the complexities of ALS.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...